Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Sell
14,116
-10
-0.1% -$1.17K 0.59% 39
2026
Q1
$1.7M Sell
14,126
-1,031
-7% -$119K 0.64% 38
2025
Q4
$1.6M Sell
15,157
-36
-0.2% -$3.38K 0.58% 40
2025
Q3
$1.28M Buy
15,193
+2,841
+23% +$234K 0.48% 54
2025
Q2
$978K Buy
12,352
+30
+0.2% +$2.38K 0.39% 70
2025
Q1
$1.11M Sell
12,322
-1,053
-8% -$98.3K 0.47% 60
2024
Q4
$1.33M Buy
+13,375
New +$1.38M 0.55% 44

Other funds holding MRK

Texas Bank & Trust's MRK Position: Q2 2026 in Review

Texas Bank & Trust reduced its Merck (MRK) stake by 0.07% in Q2 2026, selling an estimated $1.17K and leaving 14,116 shares worth $1.81M. The position accounts for 0.59% of the portfolio, ranked #39.

Texas Bank & Trust first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Texas Bank & Trust held 14,116 shares of Merck worth $1.81M as of Q2 2026.
  • Texas Bank & Trust sold 10 Merck shares in Q2 2026, an estimated $1.17K.
  • Merck made up 0.59% of Texas Bank & Trust's portfolio in Q2 2026, its #39 holding.
  • Texas Bank & Trust first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Texas Bank & Trust's 13F filing for Q2 2026, filed 31 Jul 2026.